These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 14708880)
1. The application of clinical proteomics to cancer and other diseases. Clarke W; Zhang Z; Chan DW Clin Chem Lab Med; 2003 Dec; 41(12):1562-70. PubMed ID: 14708880 [TBL] [Abstract][Full Text] [Related]
2. Proteomics: a new approach to the study of disease. Chambers G; Lawrie L; Cash P; Murray GI J Pathol; 2000 Nov; 192(3):280-8. PubMed ID: 11054709 [TBL] [Abstract][Full Text] [Related]
3. Proteomics and cancer diagnosis: the potential of mass spectrometry. Rodland KD Clin Biochem; 2004 Jul; 37(7):579-83. PubMed ID: 15234239 [TBL] [Abstract][Full Text] [Related]
4. Proteomics and cardiovascular disease: an update. Balestrieri ML; Giovane A; Mancini FP; Napoli C Curr Med Chem; 2008; 15(6):555-72. PubMed ID: 18336270 [TBL] [Abstract][Full Text] [Related]
5. Proteomics and the search for biomarkers of female reproductive diseases. Meehan KL; Rainczuk A; Salamonsen LA; Stephens AN Reproduction; 2010 Oct; 140(4):505-19. PubMed ID: 20628032 [TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry-based proteomics: current status and potential use in clinical chemistry. Binz PA; Hochstrasser DF; Appel RD Clin Chem Lab Med; 2003 Dec; 41(12):1540-51. PubMed ID: 14708878 [TBL] [Abstract][Full Text] [Related]
7. Proteomics in cancer. Reymond MA; Schlegel W Adv Clin Chem; 2007; 44():103-42. PubMed ID: 17682341 [TBL] [Abstract][Full Text] [Related]
8. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Smith JG; Gerszten RE Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806 [TBL] [Abstract][Full Text] [Related]
9. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550 [TBL] [Abstract][Full Text] [Related]
10. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK; Tyson DR Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055 [TBL] [Abstract][Full Text] [Related]
11. The ongoing evolution of proteomics in malignancy. Dhamoon AS; Kohn EC; Azad NS Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682 [TBL] [Abstract][Full Text] [Related]
12. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research. You SA; Wang QK Methods Mol Med; 2006; 129():15-26. PubMed ID: 17085802 [TBL] [Abstract][Full Text] [Related]
13. Cancer proteomics. Tan HT; Lee YH; Chung MC Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534 [TBL] [Abstract][Full Text] [Related]
14. Proteomics: methodologies and applications to the study of human diseases. Barbosa EB; Vidotto A; Polachini GM; Henrique T; Marqui AB; Tajara EH Rev Assoc Med Bras (1992); 2012; 58(3):366-75. PubMed ID: 22735231 [TBL] [Abstract][Full Text] [Related]
15. Proteomics in developmental toxicology. Barrier M; Mirkes PE Reprod Toxicol; 2005; 19(3):291-304. PubMed ID: 15686865 [TBL] [Abstract][Full Text] [Related]